Achieve Life Sciences director awarded stock grants
Achieve Life Sciences, Inc. director Aaron Royston reported equity compensation awards effective July 27, 2026.
Rhea-AI Filing Summary
Achieve Life Sciences, Inc. director Aaron Royston reported equity compensation awards effective July 27, 2026. He received stock options for 25,000 shares at a $6.18 exercise price, expiring July 27, 2036, and 16,700 RSUs. Both awards vest 100% on the earlier of July 27, 2027 or immediately before the 2027 annual stockholders meeting, subject to continued service. The options and RSUs are held for the benefit of venBio Global Strategic Fund V, L.P., with related proceeds remitted to that fund, and Royston disclaims beneficial ownership except for his pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 41,700 shares
Grant/Award
2 txns
Insider
Royston Aaron
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) F1 | 25,000 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Unit (RSU) F2, F3 | 16,700 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 25,000 contracts (Direct);
Restricted Stock Unit (RSU) — 16,700 contracts (Direct)
Footnotes (3)
- F1. The options vest 100% on the earlier of July 27, 2027 or the date immediately prior to the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's provision of service to the Issuer on the vesting date.
- F2. Each RSU represents a contingent right to receive one share of the Issuer's common stock at settlement.
- F3. Pursuant to the terms of the RSU, the shares underlying the RSU vest 100% on the earlier of July 27, 2027 or the date immediately prior to the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's provision of service to the Issuer on the vesting date.
Key Figures
Stock options granted: 25,000 shares
Option exercise price: $6.18 per share
Option expiration date: July 27, 2036
+2 more
5 metrics
Stock options granted
25,000 shares
Stock Option grant to director on July 27, 2026
Option exercise price
$6.18 per share
Exercise price of options granted on July 27, 2026
Option expiration date
July 27, 2036
Expiration of stock options granted to director
RSUs granted
16,700 units
Restricted Stock Units granted on July 27, 2026
Vesting trigger date
July 27, 2027
Awards vest 100% on this date or immediately before 2027 annual meeting, subject to service
Key Terms
Restricted Stock Unit (RSU), Stock Option (right to buy), vest 100%, pecuniary interest, +1 more
5 terms
Restricted Stock Unit (RSU) financial
"Security titled Restricted Stock Unit (RSU) with 16,700 underlying shares"
A restricted stock unit (RSU) is a promise from a company to give an employee company shares (or cash equal to their value) at a future date if certain conditions are met, such as staying with the company or hitting performance targets. For investors, RSUs matter because when they convert into actual shares they increase the number of shares available and can create selling pressure as employees cash out—think of them as a future paycheck paid in company stock.
Stock Option (right to buy) financial
"Security titled Stock Option (right to buy) for 25,000 shares at $6.18"
vest 100% financial
"The options vest 100% on the earlier of July 27, 2027 or before the 2027 meeting"
pecuniary interest regulatory
"Royston disclaims beneficial ownership except to the extent of his pecuniary interest"
Section 16 of the Securities and Exchange Act of 1934 regulatory
"Not deemed an admission of beneficial ownership for purposes of Section 16"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did ACHV director Aaron Royston report receiving?
ACHV director Aaron Royston reported a grant of 25,000 stock options at a $6.18 exercise price and 16,700 RSUs on July 27, 2026. These awards are equity compensation tied to his board role and settle in common stock if vested.
What are the key terms of Aaron Royston’s ACHV stock options?
Royston’s ACHV stock options cover 25,000 shares of common stock at a $6.18 exercise price and expire on July 27, 2036. They vest 100% on the earlier of July 27, 2027 or immediately before the company’s 2027 annual stockholders meeting, subject to continued service.
How and when do Aaron Royston’s ACHV RSUs vest?
Royston’s 16,700 ACHV RSUs vest 100% on the earlier of July 27, 2027 or the date immediately prior to Achieve Life Sciences’ 2027 annual stockholders meeting. Vesting is conditioned on his continued service to the company through the applicable vesting date.
Who benefits economically from Aaron Royston’s ACHV equity awards?
The options and RSUs are held for the benefit of venBio Global Strategic Fund V, L.P.. Under venBio policies, proceeds from option exercises, RSU settlements, and related share sales are remitted to that fund, and Royston disclaims beneficial ownership except for his pecuniary interest.
Were Aaron Royston’s ACHV awards granted under a Rule 10b5-1 plan?
These equity awards were not reported as granted under a Rule 10b5-1 trading plan, as the related checkbox was not selected. They are compensation grants, not open-market purchases or sales executed under a preset trading program.
AI-generated analysis. How Rhea-AI works. Not financial advice.
